Stryker Corp financial data

Symbol
SYK on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
1941 Stryker Way, Portage, MI
State of incorporation
MI
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 172 % +8.39%
Quick Ratio 68.6 % +0.93%
Return On Equity 18.5 % +22.9%
Return On Assets 8.85 % +27.7%
Operating Margin 19.9 % +14.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 381M shares +0.35%
Entity Public Float 110B USD +54.6%
Weighted Average Number of Shares Outstanding, Basic 381M shares +0.34%
Weighted Average Number of Shares Outstanding, Diluted 386M shares +0.42%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 22B USD +10.5%
Cost of Revenue 8.01B USD +9.75%
Research and Development Expense 1.46B USD +6.89%
Operating Income (Loss) 4.37B USD +26.7%
Nonoperating Income (Expense) -175M USD +26.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.19B USD +30.6%
Income Tax Expense (Benefit) 600M USD -3.69%
Net Income (Loss) Attributable to Parent 3.59B USD +38.9%
Earnings Per Share, Basic 9.43 USD/shares +38.5%
Earnings Per Share, Diluted 9.33 USD/shares +38.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.85B USD +107%
Accounts Receivable, after Allowance for Credit Loss, Current 3.74B USD +14%
Inventory, Net 5.29B USD +8.38%
Assets, Current 14.7B USD +32.8%
Deferred Income Tax Assets, Net 1.56B USD +11.1%
Property, Plant and Equipment, Net 3.43B USD +10.4%
Operating Lease, Right-of-Use Asset 516M USD +5.09%
Intangible Assets, Net (Excluding Goodwill) 4.94B USD +4.42%
Goodwill 16.4B USD +8.31%
Other Assets, Noncurrent 2.83B USD +8.3%
Assets 43.8B USD +15.2%
Employee-related Liabilities, Current 1.25B USD +2.21%
Liabilities, Current 7.67B USD +2.83%
Accrued Income Taxes, Noncurrent 368M USD -20.9%
Deferred Income Tax Liabilities, Net 63M USD -5.97%
Operating Lease, Liability, Noncurrent 374M USD +1.36%
Other Liabilities, Noncurrent 2.32B USD +26.7%
Liabilities 23.7B USD +17.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -545M USD -119%
Retained Earnings (Accumulated Deficit) 18.3B USD +14.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 20.1B USD +12.5%
Liabilities and Equity 43.8B USD +15.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 204M USD -54.2%
Net Cash Provided by (Used in) Financing Activities -418M USD +13.1%
Net Cash Provided by (Used in) Investing Activities -408M USD -209%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -641M USD -271%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.85B USD +107%
Deferred Tax Assets, Valuation Allowance 223M USD -21.8%
Deferred Tax Assets, Gross 2.89B USD +6.53%
Depreciation 107M USD +11.5%
Payments to Acquire Property, Plant, and Equipment 167M USD +28.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3.29B USD +35.8%
Property, Plant and Equipment, Gross 6.89B USD +11.9%
Operating Lease, Liability, Current 149M USD +14.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 108M USD +12.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 150M USD +19%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -39M USD -1200%
Lessee, Operating Lease, Liability, to be Paid, Year Three 87M USD +19.2%
Deferred Tax Assets, Operating Loss Carryforwards 385M USD +55.9%
Preferred Stock, Shares Authorized 500K shares 0%
Unrecognized Tax Benefits 371M USD +29.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 56M USD +3.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 616M USD -4.35%
Deferred Tax Assets, Net of Valuation Allowance 2.67B USD +9.85%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%